Transferring from one 100-unit/mL preparation of insulin glargine to another (i.e., Lantus to Basaglar). Dosage of Basaglar should be the same as that of the other preparation; administration time determined by clinician.Transferring from 100-unit/mL preparation to 300-unit/mL preparation of...
Lantus is a drug used in the treatment of diabetes mellitus. This drug is available as 10 mL vials or as a 3 mL cartridge system. Instructions: You should read the product information...
Lilly insulin glargine (LY IGlar; Basaglar®) and the reference insulin glargine product (IGlar; Lantus®) are basal insulin glargine analogs with identical amino acid sequence and similar pharmacological profiles. ELEMENT 5, a Phase 3, prospective, randomized, multinational, two-arm, active-...
Mayor D,Chantelan E.Treatment with insulin glargine(Lantus)increases the proliferative potency of the serum of patients with type-1 diabetes:a study on MCF-7 breast cancer cells[J].Arch Physiol Biochem,2010,116(2):73-78.Mayer D, Chantelau E. Treatment with insulin glargine (Lantus) ...
While using Lantus, do not drive or operate heavy machinery until you know how Lantus affects you. You should not drink alcohol or use other medicines that contain alcohol. The most common side effect of insulin, including Lantus, is low blood sugar (hypoglycemia), which may be serious and ...
the starting dose of TOUJEO can be the same as the once-daily long-acting dose. For patients controlled on LANTUS (insulin glargine, 100 units/mL) expect that a higher daily dose of TOUJEO will be needed to maintain the same level of glycemic control [seeCLINICAL PHARMACOLOGYandClinical Studi...
Lantus®is a registered trademark of Sanofi. This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about ABASAGLAR®(insulin glargine) as a treatment for patients with diabetes mellitus in adults, adolescents and...
Lantus, INN insulin glargine European (地特胰岛素应用,酒店欧洲人) 19 April 2012 EMA/CHMP/158966/2012 Committee for Medicinal Products for Human Use (CHMP) Assessment report Lantus insulin glargine Procedure No.: EMEA/H/C/000284/II/0075 Note Variation assessment report as adopted by the CHMP with...
Toujeo, which came to market in early 2015, is a form of man-made insulin known as insulin glargine. There are two other brands of insulin glargine on the market: Lantus (also made by Sanofi Aventis) and Basaglar (produced by Eli Lilly). Toujeo is intend
The patients were taught to inject either glargine (Lantus; Aventis Pharma, Frankfurt, Germany) or NPH (Insuman Basal, Aventis Pharma) insulin using the Optipen Pro 1 pen (Aventis Pharma). The initial bedtime insulin dose was 10 IU for all patients who were using metformin alone, and 20 ...